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Mortality after total knee arthroplasty: A systematic review of incidence, temporal trends 
and risk factors  
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Abstract 
Background: To determine a contemporary estimate of the risk of mortality following total knee 
arthroplasty (TKA), including the identification of temporal trends, common causes, and 
modifiable and non-modifiable risk factors. 
Materials and methods: Systematic review, meta-analysis and meta-regression. Searches of 
MEDLINE, AMED, CAB Abstracts, Embase, for studies in any language published between 
2006 and 2016 reporting 30 or 90 day mortality following TKA, supplemented by contact with 
authors. 
Results: Thirty-seven studies with mortality data from 15 different countries following 1.75 
million TKAs contributed to this review. The pooled Poisson-normal random-effects meta-
analysis estimate of 30 and 90 day mortality are 0.20% (95% confidence interval 0.17 to 0.24) 
and 0.39% (0.32 to 0.49). Both estimates have fallen over the study period (p<0.001). Meta-
regression using median year of surgery as a moderator shows that 30 and 90 day mortality 
following TKA fell to 0.10% (0.07 to 0.14) and 0.19% (0.15 to 0.23) in 2015. The leading 
cause of death is cardiovascular disease. 
Conclusions: There is a worldwide ongoing secular decline in mortality following TKA. 
Improved patient selection, perioperative care and a healthy population effect may account for 
this observation. Efforts to further reduce mortality should be targeted at reducing cardiovascular 
events following TKA. 
Level of evidence: I  
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Introduction 
All surgery carries risk of some kind, including death. Reporting of 30 day mortality is preferred 
to in-hospital mortality due to differences in hospital discharge practices.1,2 Mortality up to 90 
days is also widely reported. The rarity of mortality in the immediate postoperative period makes 
it difficult to investigate. However, risk of death is of paramount importance to patients, their 
significant others and to healthcare providers. The risk of postoperative death needs to be 
accurately quantified and conveyed to patients in order to inform decisions about treatment 
options. In addition, modifiable patient and surgical risk factors should be identified, so that 
measures can be taken to address them. A study of data between 2003 and 2011 from the 
National Joint Registry for England and Wales showed a marked decline in mortality following 
TKA in England and Wales.3  
We aim to characterise trends in mortality, identify modifiable and non-modifiable risk factors, 
and the leading causes of death. We hypothesise that early postoperative mortality following 
TKA is falling globally and aim to use meta-regression to predict a contemporary estimate of 30 
and 90 day mortality. 
 
Materials and methods 
The study outcomes of interest to this review were 30 and 90 day mortality following primary 
TKA. Small studies where no mortality was observed were excluded. Studies presenting only in-
hospital mortality, or other timeframes not of interest to this study were excluded. Studies 
investigating mortality within specific subgroups of the overall population of those undergoing 
primary TKA were excluded (e.g. simultaneous bilateral TKA, patients undergoing revision 
surgery, extremes of age, exclusively non-cardiac patients). Studies where hip and knee 
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arthroplasty mortality data were combined and could not be separated were excluded. To prevent 
double counting, datasets which were presented in multiple publications were only included 
once. Numerous studies report data from the American College of Surgeons National 
Surveillance Quality Improvement Project (NSQIP).4-9 To prevent double counting of NSQIP 
data within this review, three studies with overlapping data collection periods were excluded 
from pooled statistical analyses. Unique secondary findings of these studies have however been 
discussed in the narrative part of this review. 
Our review team used a rigorous systematic approach, as described in the Cochrane Handbook10 
and Meta-analysis Of Observational Studies in Epidemiology (MOOSE) guidelines,11 for the 
conduct and reporting of this review. This review was registered on the *** Blinded by JBJS 
*** database following preliminary searches, registration number: *** Blinded by JBJS ***. 
Search strategy 
We searched Ovid MEDLINE 1946 to 16th August 2016, AMED (Allied and Complementary 
Medicine) 1985 to August 2016, CAB Abstracts 1973 to 2016 Week 31, and Embase 1980 to 
2016 Week 33. Searches were performed on 16th August 2016, and included abstracts and 
studies published in any language. Using controlled vocabulary, we searched the terms, 
“mortality”, “knee”, and “replacement or arthroplasty”. Given the likely temporal association 
with mortality, and our aim to provide a contemporary estimate of mortality, searches were 
subsequently limited to studies published in the period between 2006 and 2016. We also 
searched the reference lists of articles identified by this search strategy and included additional 
studies deemed relevant. 
Screening 
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A total of 731 records were identified from searching the literature; two experienced reviewers 
(*** Blinded by JBJS ***) independently screened the titles and abstracts of these records to 
identify potentially relevant articles for inclusion in this systematic review. After screening, 37 
studies were included in this review.  
Data extraction and risk of bias assessment 
Data were extracted regarding the proportion of patients who had died at either 30 or 90 days 
postoperatively. Where adjusted or manipulated mortality data were reported, we contacted 
authors to request unadjusted rates and those who responded and provided additional data are 
acknowledged. Study and participant characteristics were also recorded (cohort size, country of 
study, median year of study data collection, mean age of patients, proportion of female patients, 
type of database used, inclusion/exclusion criteria, and risk of bias assessment). We also noted 
the causes of death, risk factors for mortality and other adverse events. The characteristics of 
included studies are available in appendix 1.  
Risk of bias was assessed using relevant parts of the Newcastle-Ottawa Quality Assessment 
Scale: Representativeness of the exposed cohort, ascertainment of exposure, assessment of 
outcome, and adequacy of follow up of cohorts. Two authors independently assessed risk of bias 
(*** Blinded by JBJS ***). 
Statistical analysis 
We used the median year of data collection for each individual study for pooled analyses. Due to 
the rarity of mortality as an outcome after TKA, as well as heterogeneity in global healthcare, 
meta-analyses and meta-regressions were conducted using a Poisson-normal model with random 
effects. Log transformed incidence rates were used as the effect measure. This approach has been 
shown to perform well in rare event studies.12 Effect estimates for individual and pooled studies 
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are summarised in forest plots and heterogeneity was assessed using the I2 statistic to quantify 
inconsistency.13 All statistical analyses were performed using the metafor package14 within the R 
statistical environment.15 
Subgroup analysis and investigation of heterogeneity 
We performed subgroup analyses to identify the sources of heterogeneity. Study size (>50,000, 
<50,000), median year of data collection (<2004, 2004-2006, 2007, >2007), geographical origin 
(USA, Europe, rest of the world), and health insurance status (Medicare, other) were used to 
stratify the data in an attempt to identify sources of heterogeneity. Meta-regressions with median 
year of data collection as a variable were conducted. 
 
Source of funding 
No funding was received for this study. 
 
Results 
We included 37 studies of mortality after TKA from fifteen different countries in four continents 
where unadjusted 30 or 90 day mortality rates were recorded or made available by the authors.3-
9,16-45 Of these, 27 studies published between 2006 and 2016 reported 30 day mortality. Due to 
overlapping data, 3 were excluded and the remaining 24 of these studies were pooled. These 
included 1,753,449 TKAs performed between 1991 and 2014. The pooled 30 day Poisson-
normal random-effects estimate of mortality over the study period was 0.20% (95% confidence 
interval 0.17 to 0.24), see figure 1. The pooled 90 day estimate of mortality was 0.39% (0.32 to 
0.49), according to seventeen studies published between 2006 and 2016 including 700,981 TKAs 
performed between 1991 and 2014, see figure 2. 
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Three studies reported a secular decline in mortality observed within their cohorts.3,25,40 Using 
meta-regression, a strong correlation towards a secular reduction in mortality was observed when 
the median year of surgery for each individual study was used as a moderator (p<0.000005), see 
figure 3. Log transformed incidence rates were used with a Poisson-normal random-effects 
model to show that 30 day mortality following TKA in 2015 was 0.10% (0.07 to 0.14). 
Heterogeneity fell from 95% to 88% with this model suggesting that significant variation in 
global healthcare still exists. The trend for 90 day mortality was similar (p<0.001). Meta-
regression modelling shows that 90 day mortality following TKA in 2015 was 0.19% (0.15 
to 0.23), see figure 4.  
There were no differences in mortality between continents when meta-regressions included 
origin of study as a moderator (p>0.6). Controlling for the secular trend towards declining 
mortality in meta-regressions comparing continent of study further reduced the statistical 
significance (p>0.9). 
The period of increased mortality risk following TKA has been described in four studies.3,30,35,45 
Risk of mortality is highest in the first ten days30 then returns to preoperative baseline rates 
within 21 days,30 thirty days,35,45 or 45 days.3 Postoperative mortality was five times higher in the 
first 30 days compared with the same period prior to surgery, and when corresponding 90 day 
periods were analysed the post-operative mortality rate was double that of the equivalent pre-
operative period.35 In a similar study, 30 day mortality for the age category of 61 to 70 years 
tripled postoperatively from baseline rates.30 
Cardiovascular causes, particularly myocardial infarction were cited as the commonest cause of 
death in all studies where cause of death was reported. 4,28,35,38,41 Two multivariate adjusted 
studies identify a prior cardiac event as a significant risk factor for postoperative 90 day 
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mortality (OR 3.0, 95% CI 1.7 to 5.4),40 and 45 day mortality (hazard ratio 3·46, 95% CI 2·81 to 
4·14).3 Pulmonary embolus and cerebrovascular accident appear to be the next most common 
causes of death.35,41 With time, other unrelated causes of death become increasingly prevalent. 
For example, in a study of 90 day mortality, malignancy accounted for 14% of deaths.35  
Diabetes mellitus was identified as a medical comorbidity in 18.2% of patients undergoing TKA 
in a study by Belmont and colleagues from the USA. On multivariate logistic regression analysis, 
controlling for known risk factors for mortality, a diagnosis of diabetes was still associated with 
increased odds of mortality (OR = 2.99, 95% confidence interval 1.35 to 6.62).4   
Seven studies reported increasing age as an independent risk factor for 30 day5,30,31,33,45 and 90 
day36,40 mortality following TKA, when controlling for co-morbidities and other confounders.  
Male gender appeared to be an important risk factor for mortality at 30 and 90 days compared 
with female gender (odds ratio 1.9 and 1.7, p<0.001), in a multivariate analysis controlling for 
age and comorbidities in over 200,000 TKAs,45 confirmed by similar odds ratios in three other 
studies.30,36,40 
Ethnicity did not appear to confer a difference in 30 day mortality,19,45 however at longer term 
follow up (60 to 180 days) lower mortality was observed in Asian patients on multivariate 
analysis.45 
Being mildly overweight appeared to confer a protective effect following TKA. Models adjusted 
for other comorbidities reveal lowest mortality in the BMI category 26-30 kg/m² (hazard ratio 
0·69, 95% confidence interval 0·54 to 0·88) when referenced to a normal BMI of 19–25 kg/m².3 
Smaller studies have not been able to identify an association between mortality and BMI. 4,9 
Cerebrovascular disease, liver disease and renal disease conferred statistically significant hazard 
ratios of mortality of 3·4, 7·2, and 2·2 respectively in the study by Hunt and colleagues.3  
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North America is represented in 21 studies, Europe in 11 studies, Asia in three studies and 
Australia in two studies.  
Overall there was a low risk of bias within the studies included in this review, however most 
studies were performed in a subset of the overall population undergoing TKA, e.g. Medicare or 
NHS patients only. A summary of the risk of bias assessment is presented in table 1. 
 
Discussion 
This analysis identifies a strong worldwide temporal decline in 30 and 90 day mortality 
following TKA. Although causality cannot be determined, a possible explanation for this decline 
may be related to improvements in healthcare over the past twenty years. For this trend towards 
decreasing mortality to continue, healthcare providers will need to address the major cause of 
early post-operative mortality, identified as cardiovascular disease in our study. 
Another possible explanation for declining mortality could be related to improving health and 
life expectancy of the population. The study by Hunt and colleagues showed that mortality 
following TKA fell at a faster rate than that expected when compared with the general 
population.3 Although the results of our study may indicate improvements in population life 
expectancy, it appears that this may not fully explain the trends we observe. Other studies 
comparing postoperative mortality with the general population are at risk of underestimating the 
risk associated with surgery due to a selection bias towards operating on healthy patients. 
Significant variation in the reported mortality following TKA is observed worldwide. This may 
be due to differences in the underlying populations or the delivery of healthcare. It is unlikely 
that differences in study design would account for the observed heterogeneity. All of the 
available studies report retrospective cohorts or retrospective analysis of prospectively collected 
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data. Although the risk of bias was low in most studies, and it appeared that adequate processes 
were followed to ascertain the mortality status of patients at 30 and 90 days, there remains a 
greater potential for under rather than over-reporting mortality. This may have the effect of 
reducing the mortality estimates we present. 
The identification of modifiable risk factors is of paramount importance to healthcare providers, 
and efforts to address the risk from cardiovascular disease, diabetes and extremes of BMI should 
be encouraged. The protective effect of being mildly overweight has been identified in studies of 
mortality in other disciplines and has been termed the obesity paradox.46,47 Age and male gender 
have also been confirmed as independent risk factors for mortality.  
In summary, TKA is a safe procedure associated with low rates of mortality. A strong 
international secular trend towards declining mortality has emerged. Efforts to reduce 
cardiovascular and diabetes related risks may reduce mortality further.  
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Figure Legends 
Figure 1: Forest plot of Poisson-normal random-effects model for studies reporting 30 day 
mortality ordered by median year of study data collection. 
Figure 2: Forest plot of Poisson-normal random-effects model for studies reporting 90 day 
mortality ordered by median year of study data collection. 
Figure 3: Meta-regression bubble plot of 30 day mortality against median year of study data 
collection.  
Figure 4: Meta-regression bubble plot of 90 day mortality against median year of study data 
collection. 
